NEUROPSYCHOPHARMACOLOGY

NEUROPSYCHOPHARMACOLOGY(英文缩写 NEUROPSYCHOPHARMACOL),ISSN 0893-133X,eISSN 1740-634X 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

NEUROPSYCHOPHARMACOLOGY 最新收录文献

1. Grand challenges for psychiatric drug discovery: a perspective.
   Linda S Brady, Robert B Giffin, Janet Woodcock, Gail H Cassell, Edward W Holmes
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18626470
   查看详情 DOI
2. Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settings.
   P Jeffrey Conn, Bryan L Roth
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18216778

   Despite significant progress in understanding the biological systems and mechanisms involved in CNS disorders, use of this knowledge to realize practical gains in psychiatric care has been slow. To ga…

   查看详情 DOI
3. Novel drugs and therapeutic targets for severe mood disorders.
   Sanjay J Mathew, Husseini K Manji, Dennis S Charney
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18172433

   Monoaminergic-based drugs remain the primary focus of pharmaceutical industry drug discovery efforts for mood disorders, despite serious limitations regarding their ability to achieve remission. The q…

   查看详情 DOI
4. Neural pathways underlying lactate-induced panic.
   Philip L Johnson, William A Truitt, Stephanie D Fitz, Christopher A Lowry, Anantha Shekhar
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18059441

   Panic disorder is a severe anxiety disorder characterized by susceptibility to induction of panic attacks by subthreshold interoceptive stimuli such as 0.5 M sodium lactate infusions. Although studied…

   查看详情 DOI
5. Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine.
   Matthew I Palmatier, Xiu Liu, Eric C Donny, Anthony R Caggiula, Alan F Sved
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18046312

   Nicotine self-administration models typically evaluate the effects of smoking cessation aides on 'primary reinforcement' engendered by nicotine. However, the more recently described reinforcement enha…

   查看详情 DOI
6. The evolution of drug development in schizophrenia: past issues and future opportunities.
   William T Carpenter, James I Koenig
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18046305

   Schizophrenia is a disease syndrome with major public health implications. The primary advance in pharmacotherapeutics was in 1952 with the introduction of antipsychotic medications (ie, chlorpromazin…

   查看详情 DOI
7. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
   Monica Beneyto, James H Meador-Woodruff
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18033238

   The hypothesis of N-methyl-D-aspartate (NMDA) receptor hypofunction in schizophrenia was initially based on observations that blockade of the NMDA subtype of glutamate receptor by noncompetitive antag…

   查看详情 DOI
8. Spontaneous nicotine withdrawal potentiates the effects of stress in rats.
   Sietse Jonkman, Victoria B Risbrough, Mark A Geyer, Athina Markou
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18033237

   Anxiety is a common symptom of nicotine withdrawal in humans, and may predict an inability to abstain from cigarette smoking. It is not clear if self-reports of anxiety during abstinence reflect incre…

   查看详情 DOI
9. Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.
   Richard Exley, Michael A Clements, Henrike Hartung, J Michael McIntosh, Stephanie J Cragg
   Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18033235

   Modulation of striatal dopamine (DA) neurotransmission plays a fundamental role in the reinforcing and ultimately addictive effects of nicotine. Nicotine, by desensitizing beta2 subunit-containing (be…

   查看详情 DOI
10. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
    Suzie Lavoie, Micah M Murray, Patricia Deppen, Maria G Knyazeva, Michael Berk, Olivier Boulat
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008 IF: 7.60 Q1 PMID: 18004285

    In schizophrenia patients, glutathione dysregulation at the gene, protein and functional levels, leads to N-methyl-D-aspartate (NMDA) receptor hypofunction. These patients also exhibit deficits in aud…

    查看详情 DOI